Garheng Kong
(Dr. Garheng Kong M.D., PH.D.)
Hält derzeit Positionen bei Alimera Sciences Inc, Laboratory Corporation of America Holdings and Strongbridge Biopharma plc
Position
| Position | Company | Period |
|---|---|---|
| Independent Director | Alimera Sciences Inc | 1. Oktober 2012 - |
| Independent Director | Laboratory Corporation of America Holdings | 1. Dezember 2013 - |
| Lead Independent Director | Strongbridge Biopharma plc | 18. November 2019 - |
| Independent Director | Melinta Therapeutics Inc | 1. Januar 2016 - 11. Juni 2019 |
| Independent Chairman of the Board | Ocugen Inc | 1. Juli 2012 - 22. Februar 2019 |
| Independent Chairman of the Board | Melinta Therapeutics Inc | 1. November 2008 - 1. Januar 2016 |
Garheng Kong's trades of Venus Concept Inc's stock
Loading...
•
Kauf
•
Verkauf
•
Geplanter Kauf
•
Geplanter Verkauf
Netto-Kauf
Netto-Verkauf
Earnings
Abkürzungen K: Kauf, V: Verkauf, GK: Geplanter Kauf, GV: Geplanter Verkauf, S: Sonstiges
